| Literature DB >> 32601945 |
Sung Eun Kim1, Kyeongsoon Park2.
Abstract
Biphasic calcium phosphate bioceramics consist of an intimate mixture of hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP) in varying ratios. Due to their biocompatibility, osteoconductivity, and safety in in vitro, in vivo, and clinical models, they have become promising bone substitute biomaterials and are recommended for use as alternatives for or as additives in bone tissue regeneration in various orthopedic and dental applications. Many studies have demonstrated the potential uses of BCP bioceramics as scaffolds for tissue engineering. Here, we highlight the recent advances in the uses of BCP bioceramics and functionalized BCPs for bone tissue regeneration.Entities:
Keywords: Drug delivery; Injectable BCP/polymer; Marked BCP; Osseointegration; Osteoinductive growth factors
Mesh:
Substances:
Year: 2020 PMID: 32601945 DOI: 10.1007/978-981-15-3262-7_12
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622